Skip to main content
SpringerLink
Log in

Portal Vein Thrombosis in Patients with End Stage Liver Disease Awaiting Liver Transplantation: Outcome of Anticoagulation

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

The prevalence of portal vein thrombosis (PVT) increases with the severity of liver disease. Development of PVT is often accompanied by increased rate of morbidity and mortality and may affect patient candidacy for liver transplant. There is limited data regarding the role of anticoagulation therapy in patients with PVT and liver cirrhosis.

Objectives

The aims of this study were to describe the prevalence of hypercoagulable disorders in patients with liver cirrhosis and PVT, and to describe the outcome of anticoagulation in patients with liver cirrhosis and PVT.

Methods

A retrospective chart review was conducted of patients with liver cirrhosis awaiting liver transplant who were diagnosed with PVT between January 2005 and November 2011.

Results

During the study period, 537 patients were evaluated for liver transplant. Sixty-nine (13 %) patients were diagnosed with portal vein thrombosis. Chronic hepatitis C was the cause of liver disease in 24/69 (35 %) patients, and hepatocellular carcinoma was present in 39 % of patients. In 22 patients screened for hypercoagulable disorders, hypercoagulable disorder was diagnosed in one patient (5 %). Twenty-eight (28/69) patients were treated during the study period with warfarin: PVT resolved in 11/28 (39 %), no change in 5/28 (18 %), and 12/28 (43 %) patients showed partial resolution of thrombus. Eight patients received liver transplant while on anticoagulation, and operative notes confirmed patency of PV in all eight patients.

Conclusions

PVT is frequently seen in patients with end stage liver disease with prevalence of 13 %. Hypercoagulable disorder was detected in 5 % of the patients screened. Careful use of anticoagulation is safe and effective in patients with PVT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Primignani M. Portal vein thrombosis, revisited. Dig Liver Dis. 2009;42:163–170.

    Article  PubMed  Google Scholar 

  2. Aqel B. Vascular diseases of the liver. In: Talley N, Lindor KD, Vargas HE, eds. Liver and Biliary Disease. Oxford: Wiley-Blackwell; 2010:267–273.

    Google Scholar 

  3. Julapalli VR, Bray PF, Duchini A. Elevated factor VIII and portal vein thrombosis. Dig Dis Sci. 2003;48:2369–2371.

    Article  PubMed  Google Scholar 

  4. Rodriguez-Luna H, Vargas HE. Portal vein thrombosis. Current Treat Options Gastroenterol. 2007;10:435–443.

    Article  Google Scholar 

  5. Northup PG, Sundaram V, Fallon MB, et al. Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost. 2008;6:2–9.

    PubMed  CAS  Google Scholar 

  6. Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology. 1995;21:1238–1247.

    PubMed  CAS  Google Scholar 

  7. Amitrano L, Guardascione MA, Ames PR. Coagulation abnormalities in cirrhotic patients with portal vein thrombosis. Clin Lab. 2007;53:583–589.

    PubMed  Google Scholar 

  8. Cho JY, Suh KS, Shin WY, Lee HW, Yi NJ, Lee KU. Thrombosis confined to the portal vein is not a contraindication for living donor liver transplantation. World J Surg. 2008;32:1731–1737.

    Article  PubMed  Google Scholar 

  9. Englesbe MJ, Kubus J, Muhammad W, et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl. 2010;16:83–90.

    Article  PubMed  Google Scholar 

  10. Karatzas T, Lykaki-Karatzas E, Demirbas A, et al. Management of portal vein thrombosis in liver transplantation. Transpl Proc. 1997;29:2866–2867.

    Article  CAS  Google Scholar 

  11. Joh JH, Kim DI. Mesenteric and portal vein thrombosis: treated with early initiation of anticoagulation. Eur J Vasc Endovasc Surg. 2005;29:204–208.

    Article  PubMed  Google Scholar 

  12. Amitrano L, Guardascione MA, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004;40:736–741.

    Article  PubMed  Google Scholar 

  13. Amitrano L, Brancaccio V, Guardascione MA, et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology. 2000;31:345–348.

    Article  PubMed  CAS  Google Scholar 

  14. Mangia A, Margaglione M, Cascavilla I, et al. Anticardiolipin antibodies in patients with liver disease. Am J Gastroenterol. 1999;94:2983–2987.

    Article  PubMed  CAS  Google Scholar 

  15. Romero Gomez M, Suarez Garcia E, Lopez Lacomba D, Marchante I, Grande L, Castro Fernandez M. Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol. 2000;31:237–240.

    Article  PubMed  CAS  Google Scholar 

  16. Martinelli I, Primignani M, Aghemo A, et al. High levels of factor VIII and risk of extra-hepatic portal vein obstruction. J Hepatol. 2009;50:916–922.

    Article  PubMed  CAS  Google Scholar 

  17. Tripodi A, Primignani M, Chantarangkul V, et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology. 2009;137:2105–2111.

    Article  PubMed  CAS  Google Scholar 

  18. Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology. 2000;32:466–470.

    Article  PubMed  CAS  Google Scholar 

  19. Condat B, Pessione F, Hillaire S, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120:490–497.

    Article  PubMed  CAS  Google Scholar 

  20. Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut. 2005;54:691–697.

    Article  PubMed  CAS  Google Scholar 

  21. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236.

    Article  PubMed  Google Scholar 

  22. DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology. 2009;49:1729–1764.

    Article  PubMed  CAS  Google Scholar 

  23. Englesbe MJ, Schaubel DE, Cai S, Guidinger MK, Merion RM. Portal vein thrombosis and liver transplant survival benefit. Liver Transpl. 2010;16:999–1005.

    Article  PubMed  Google Scholar 

  24. Blum U, Haag K, Rossle M, et al. Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology. 1995;195:153–157.

    PubMed  CAS  Google Scholar 

  25. Radosevich PM, Ring EJ, LaBerge JM, et al. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion. Radiology. 1993;186:523–527.

    PubMed  CAS  Google Scholar 

  26. Luca A, Miraglia R, Caruso S, et al. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut. 2011;60:846–852.

    Article  PubMed  Google Scholar 

  27. Senzolo M, Ferronato C, Burra P, Sartori MT. Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered. Intern Emerg Med. 2009;4:161–162; author reply 3–4.

    Google Scholar 

  28. Amitrano L, Guardascione MA, Menchise A, et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol. 2009;44:448–451.

    Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Mayo Clinic, E Mayo Blvd. 5777, Phoenix, AZ, 85054, USA

    K. T. Werner, Shawna Sando, Elizabeth J. Carey, Hugo E. Vargas, Thomas J. Byrne, David D. Douglas, M. E. Harrison, Jorge Rakela & Bashar A. Aqel

Authors
  1. K. T. Werner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shawna Sando
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elizabeth J. Carey
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hugo E. Vargas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thomas J. Byrne
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David D. Douglas
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. E. Harrison
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jorge Rakela
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bashar A. Aqel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bashar A. Aqel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Werner, K.T., Sando, S., Carey, E.J. et al. Portal Vein Thrombosis in Patients with End Stage Liver Disease Awaiting Liver Transplantation: Outcome of Anticoagulation. Dig Dis Sci 58, 1776–1780 (2013). https://doi.org/10.1007/s10620-012-2548-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-012-2548-y

Keywords

Search

Navigation